J Biopharm Stat. 2022 Sep 3;32(5):652-670. doi: 10.1080/10543406.2021.2011905. Epub 2021 Dec 28.
We consider the case of pediatric dose-finding trials with extremely limited sample size. The operating characteristics of the standard design, the Continual Reassessment Method (CRM), are only well described for sample sizes of about 20 patients or more. In this simulation study, we assume the situation of a pediatric trial with only 10 patients and a preceding dose-finding trial in adults. Based on the adult data, we reduce the set of pediatric doses and formulate (partially) informative prior distributions for the pediatric trial. Our simulations show that such small pediatric dose-finding trials with robustified priors may provide sufficient operating characteristics.
我们考虑了样本量非常有限的儿科剂量探索试验的情况。标准设计(CRM)的操作特性仅在样本量约为 20 例或更多的情况下得到很好的描述。在这项模拟研究中,我们假设只有 10 例患者和先前的成人剂量探索试验的儿科试验情况。基于成人数据,我们减少了儿科剂量集,并为儿科试验制定(部分)信息先验分布。我们的模拟表明,具有稳健化先验的这种小型儿科剂量探索试验可能具有足够的操作特性。